BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Blocking CXCL1 signaling for hand, foot and mouth neuropathology

By biocentury staff
April 1, 2022 5:03 AM UTC

DISEASE CATEGORY: Infectious

INDICATION: Enterovirus...

BCIQ Company Profiles

Astrazeneca plc

National University of Singapore

BCIQ Target Profiles

CXC chemokine receptor 2 (CXCR2) (IL8RB)

Chemokine CXC motif ligand 1 (CXCL1) (GRO) (MGSA)

BCIQ Company Profiles

Astrazeneca plc

National University of Singapore

BCIQ Target Profiles

CXC chemokine receptor 2 (CXCR2) (IL8RB)

Chemokine CXC motif ligand 1 (CXCL1) (GRO) (MGSA)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS